Brief: Sebacia Announces Favorable Ruling By U.S. Court Regarding Patent Proceedings With Sienna Biopharma
May 7 (Reuters) - Sebacia Inc:
* SEBACIA - ANNOUNCES FAVORABLE RULING BY U.S. FEDERAL COURT
REGARDING PATENT INTERFERENCE PROCEEDINGS WITH SIENNA
BIOPHARMACEUTICALS INC
* SEBACIA - RULING RELATES TO PATENT INTERFERENCE PROCEEDING
BETWEEN GENERAL HOSPITAL CORP, OWNER OF SOME OF CO'S LICENSED
PATENTS, & SIENNA BIOPHARMACEUTICALS
* SEBACIA SAYS FEDERAL CIRCUIT RULED IN FAVOR OF GHC
REGARDING A
PATENT INTERFERENCE PROCEEDING CONCERNING SIENNA'S PATENT NO.
8,812,941
Source text for Eikon: ID:nPn7TzPX3a
Further company coverage: SNNA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sienna Biopharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Adobe, Oracle, Snap, Phreesia, Sarepta, Aquestive Therapeutics, Patterson-UTI
U.S. STOCKS ON THE MOVE-Lululemon, GE, Starbucks, Delta Air Lines, Lumber Liquidators, Lovesac
Sienna Biopharma: Falls on Nasdaq delisting plans
Brief: Sienna Biopharma Says Bankruptcy Court Approved Sale Of Assets Related To SNA-001 For $1.7 Mln In Cash
Brief: Sienna Biopharmaceuticals Announces Court Approval Of Chapter 11 Bidding Procedures